Information Journal Paper
APA:
Copy. (2018). Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial. DIABETES CARE, 41(9), 1938-1946. SID. https://sid.ir/paper/778973/en
Vancouver:
Copy. Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial. DIABETES CARE[Internet]. 2018;41(9):1938-1946. Available from: https://sid.ir/paper/778973/en
IEEE:
Copy, “Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial,” DIABETES CARE, vol. 41, no. 9, pp. 1938–1946, 2018, [Online]. Available: https://sid.ir/paper/778973/en